Oncolytics Biotech Income Statement (2009-2025) | ONCY

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Shares Outstanding (Entity) (Quarter)
0.37B0.42B0.41B0.40B0.42B0.43B0.42B0.41B0.44B
Revenue & cost
Revenue (Quarter)
0.00B-0.00B
Operating items
Amortization - Intangibles (Quarter)
Depreciation & Amortization - Total (Quarter)
26.3917.44
Research & Development (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B
Wages, Salaries and Other (Quarter)
0.00B0.00B
Share-based Compensation (IS) (Quarter)
Selling, General & Administrative (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Restructuring Costs (Quarter)
0.00B85.0388.65
Other Operating Expenses (Quarter)
0.00B0.00B-0.00B-0.00B-0.00B-0.00B
Operating Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.00B0.00B0.01B
Operating Income (Quarter)
EBIT (Quarter)
-0.01B0.01B0.00B-0.04B-0.01B0.00B-0.00B-0.03B-0.00B-0.01B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Non-operating items
Non Operating Investment Income (Quarter)
-0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
-0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B-0.00B739.70-0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B
Net income details
EBT (Quarter)
-0.01B0.01B0.00B-0.04B-0.01B0.00B-0.00B-0.03B-0.00B-0.01B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Tax Provisions (Quarter)
-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B
Profit After Tax (Quarter)
-0.01B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.01B-0.01B-0.01B-0.01B-0.00B-0.00B-0.01B
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)
-0.01B0.01B0.00B-0.04B-0.01B0.00B-0.00B-0.03B-0.00B-0.01B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Income from Discontinued Operations (Quarter)
Consolidated Net Income (Quarter)
-0.01B0.01B0.00B-0.04B-0.01B0.00B-0.00B-0.03B-0.00B-0.01B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Income towards Parent Company (Quarter)
-0.01B0.01B0.00B-0.04B-0.01B0.00B-0.00B-0.03B-0.00B-0.01B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Net Income towards Common Stockholders (Quarter)
0.01B0.01B0.00B-0.04B-0.01B0.00B-0.00B-0.03B-0.00B-0.01B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Additional items
EPS (Basic) (Quarter)
0.100.110.07-0.67-0.100.07-0.05-0.52-0.08-0.090.11-0.04-0.07-0.09-0.07-0.05-0.11
EPS (Diluted) (Quarter)
0.100.120.08-0.67-0.100.07-0.06-0.52-0.08-0.100.13-0.04-0.08-0.10-0.07-0.06-0.14
Shares Outstanding (Quarter)
0.05B0.05B0.05B0.05B0.06B0.06B0.06B0.06B0.06B0.06B0.07B0.07B0.08B0.08B0.08B0.08B0.08B0.09B0.10B0.10B
Shares Outstanding (Diluted) (Quarter)
0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.06B0.06B0.06B0.06B0.07B0.07B0.07B0.07B0.08B0.08B0.08B0.08B0.10B
EBITDA (Quarter)
-0.01B0.01B0.00B-0.04B-0.01B0.00B-0.00B-0.03B-0.00B-0.01B0.01B-0.00B-0.01B-0.01B-0.01B-0.00B-0.01B
Interest Expenses (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.04B
Tax Rate (Quarter)
-0.15-0.13-0.500.050.140.62-0.071.121.330.130.291.27-1.72